Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma.
Leuk Lymphoma
; 63(13): 3217-3221, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-36070587
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Panniculitis
/
Lymphoma, T-Cell
/
Lymphoma, T-Cell, Cutaneous
/
Hematopoietic Stem Cell Transplantation
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Leuk Lymphoma
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2022
Document type:
Article
Affiliation country:
Australia